Lumosa Therapeutics Co (ROCO:6535) Minority Interest: NT$7.35 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6535 Lumosa Therapeutics Co Ltd ROCO:6535
64 GF Score
Price NT$85.90
GF Value NT$137.91
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Lumosa Therapeutics Co Minority Interest?

Lumosa Therapeutics Co ROCO:6535 -0.23% 64 Minority Interest is NT$7.35 Mil as of Jun. 2026. GuruFocus rates ROCO:6535 with a GF Score™ of 64/100 and a GF Value™ of NT$137.91 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Lumosa Therapeutics Co's minority interest for the quarter that ended in Jun. 2026 was NT$7.35 Mil.

Lumosa Therapeutics Co Minority Interest Historical Data

* Premium members only.

The historical data trend for Lumosa Therapeutics Co's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumosa Therapeutics Co Minority Interest Chart

Lumosa Therapeutics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 40.18 27.89 15.84 9.76

Lumosa Therapeutics Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.56 11.13 9.76 8.71 7.35
ROCO:6535
64GF Score
Lumosa Therapeutics Co Ltd ROCO:6535
Minority Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lumosa Therapeutics Co Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Frequently Asked Questions Learn more about Minority Interest →
What does a Minority Interest of NT$7.35 Mil mean?
Lumosa Therapeutics Co (ROCO:6535) has a Minority Interest of NT$7.35 Mil as of Jun. 2026. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Lumosa Therapeutics Co.
Is Lumosa Therapeutics Co's Minority Interest too high?
Lumosa Therapeutics Co's current Minority Interest is NT$7.35 Mil. Overall, Lumosa Therapeutics Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lumosa Therapeutics Co's Minority Interest compare to VRTX and REGN?
Lumosa Therapeutics Co's Minority Interest of NT$7.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Minority Interest for a Biotechnology company?
A good Minority Interest depends on the Biotechnology industry context. However, Minority Interest should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Minority Interest mean?
A high Minority Interest can signal that a stock is expensive relative to its fundamentals. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Lumosa Therapeutics Co. Lumosa Therapeutics Co's current Minority Interest is NT$7.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumosa Therapeutics Co stock overvalued right now?
Based on GuruFocus' analysis, Lumosa Therapeutics Co (ROCO:6535) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$137.91, compared to a current price of NT$85.90 — trading 37.7% below its estimated fair value. The current Minority Interest is NT$7.35 Mil. Lumosa Therapeutics Co's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Minority Interest calculated?
Minority Interest is calculated from a company's financial statements. For Lumosa Therapeutics Co (ROCO:6535), the current Minority Interest is NT$7.35 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lumosa Therapeutics Co (ROCO:6535) Overvalued in 2026?

Based on GuruFocus' analysis, Lumosa Therapeutics Co stock appears to be undervalued. The current stock price of NT$85.90 is trading 37.7% below its estimated GF Value™ of NT$137.91. GuruFocus considers Lumosa Therapeutics Co to be Significantly Undervalued.

Key valuation signals for ROCO:6535:

  • Minority Interest: NT$7.35 Mil
  • GF Value™: NT$137.91 vs. price of NT$85.90 (37.7% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6535 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lumosa Therapeutics Co Business Description

Address Park Street, 4th Floor, No. 3-2, Nangang District, Taipei, TWN, 11503
Lumosa Therapeutics Co Ltd develops new drugs. The company is engaged in the development of drugs for unmet medical needs in the fields of oncology and Neuroscience. Geographically, it derives a majority of its revenue from Taiwan and also has a presence in Asia, and America. The product pipeline of the company is Neuroscience, which includes LT 1001 for Postoperative Pain, LT 3001 for Acute Ischemic Stroke, LT 5001 for Uremic Pruritus, LT 6001 for Neurological disorder, and Oncology, including LT 2003 for Solid Tumor. It generates revenue from sales of goods.
64GF Score

Get the complete analysis for ROCO:6535

Minority Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$85.90
Price
NT$137.91
GF Value